title: Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.
authors.affiliation: Faculty of Economics, Università Cattolica del Sacro Cuore, Rome, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Ruggeri
authors.affiliation: Division of Nephrology, Sant'Anna Hospital, Como, Italy.|Department of Health Sciences, University of Milan, Milan, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Bellasi
authors.affiliation: Market Access and Corporate Affairs, Genzyme, Italy.
authors.forename: Filippo
authors.initials: F
authors.lastname: Cipriani
authors.affiliation: Division of Renal Dis and Hypertension, Department of Medicine, University of Texas Houston Medical School, Houston, TX, USA.
authors.forename: Donald
authors.initials: D
authors.lastname: Molony
authors.affiliation: Division of Pediatric Nephrology, Department of Pediatrics, University of Texas Houston Medical School, Houston, TX, USA.
authors.forename: Cynthia
authors.initials: C
authors.lastname: Bell
authors.affiliation: Department of Nephrology, School of Medicine, Federico II University, Naples, Italy.
authors.forename: Domenico
authors.initials: D
authors.lastname: Russo
authors.affiliation: Department of Nephrology, Ospedale A. Landolfi di Solofra, Solofra (AV), Italy. br.diiorio@gmail.com.
authors.forename: Biagio
authors.initials: B
authors.lastname: Di Iorio